Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

SHBG may be a useful early indicator and treatment target for PCOS.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Women losing hair might have lower levels of vitamin D.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Muscles can make their own androgens, which may help muscle growth.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.